Levy Noah G.
CIK 0001788608 Name as filed on the most recent filing
Filed as Levy Noah G. (24)
66 transaction lines · from 24 filings · filed 2020-04-07 to 2023-01-17 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
0 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2023-01-12 |
Merrimack Pharmaceuticals Inc MACK |
P, Open-market purchase | 100,000 acquired | 11.90 | 1,190,000.00 | Form 4, filing 0000899243-23-001838 | |
| 2023-01-03 |
Merrimack Pharmaceuticals Inc MACK |
P, Open-market purchase | 5,300 acquired | 11.24 | 59,563.52 | Form 4, filing 0000899243-23-000580 | |
| 2022-12-30 |
Merrimack Pharmaceuticals Inc MACK |
P, Open-market purchase | 1,300 acquired | 11.24 | 14,614.99 | Form 4, filing 0000899243-23-000580 | |
| 2022-07-13 |
Merrimack Pharmaceuticals Inc MACK |
P, Open-market purchase | 3,095 acquired | 5.89 | 18,226.76 | Form 4, filing 0000899243-22-026124 | |
| 2022-07-12 |
Merrimack Pharmaceuticals Inc MACK |
P, Open-market purchase | 2,816 acquired | 5.86 | 16,515.56 | Form 4, filing 0000899243-22-026020 | |
| 2022-07-11 |
Merrimack Pharmaceuticals Inc MACK |
P, Open-market purchase | 700 acquired | 5.97 | 4,181.59 | Form 4, filing 0000899243-22-026020 | |
| 2022-07-08 |
Merrimack Pharmaceuticals Inc MACK |
P, Open-market purchase | 1,378 acquired | 5.99 | 8,249.12 | Form 4, filing 0000899243-22-025909 | |
| 2022-07-07 |
Merrimack Pharmaceuticals Inc MACK |
P, Open-market purchase | 1,100 acquired | 5.99 | 6,586.03 | Form 4, filing 0000899243-22-025909 | |
| 2022-06-30 |
Merrimack Pharmaceuticals Inc MACK |
P, Open-market purchase | 1,550 acquired | 5.76 | 8,921.49 | Form 4, filing 0000899243-22-024972 | |
| 2022-06-24 |
Merrimack Pharmaceuticals Inc MACK |
P, Open-market purchase | 1,000 acquired | 5.99 | 5,990.00 | Form 4, filing 0000899243-22-024187 | |
| 2022-06-23 |
Merrimack Pharmaceuticals Inc MACK |
P, Open-market purchase | 500 acquired | 6.00 | 3,000.00 | Form 4, filing 0000899243-22-024187 | |
| 2022-06-17 |
Merrimack Pharmaceuticals Inc MACK |
P, Open-market purchase | 515 acquired | 5.97 | 3,074.14 | Form 4, filing 0000899243-22-023332 | |
| 2022-06-17 |
Merrimack Pharmaceuticals Inc MACK |
P, Open-market purchase | 385 acquired | 5.97 | 2,298.14 | Form 4, filing 0000899243-22-023332 | |
| 2022-06-16 |
Merrimack Pharmaceuticals Inc MACK |
P, Open-market purchase | 297 acquired | 5.45 | 1,618.06 | Form 4, filing 0000899243-22-023332 | |
| 2022-06-16 |
Merrimack Pharmaceuticals Inc MACK |
P, Open-market purchase | 223 acquired | 5.45 | 1,214.90 | Form 4, filing 0000899243-22-023332 | |
| 2022-06-15 |
Merrimack Pharmaceuticals Inc MACK |
P, Open-market purchase | 1,659 acquired | 5.37 | 8,902.03 | Form 4, filing 0000899243-22-022785 | |
| 2022-06-15 |
Merrimack Pharmaceuticals Inc MACK |
P, Open-market purchase | 1,241 acquired | 5.37 | 6,659.08 | Form 4, filing 0000899243-22-022785 | |
| 2022-06-14 |
Merrimack Pharmaceuticals Inc MACK |
P, Open-market purchase | 11,977 acquired | 5.17 | 61,960.61 | Form 4, filing 0000899243-22-022785 | |
| 2022-06-14 |
Merrimack Pharmaceuticals Inc MACK |
P, Open-market purchase | 8,961 acquired | 5.17 | 46,357.94 | Form 4, filing 0000899243-22-022785 | |
| 2022-06-13 |
Merrimack Pharmaceuticals Inc MACK |
P, Open-market purchase | 5,548 acquired | 5.15 | 28,565.54 | Form 4, filing 0000899243-22-022373 | |
| 2022-06-13 |
Merrimack Pharmaceuticals Inc MACK |
P, Open-market purchase | 4,151 acquired | 5.15 | 21,372.67 | Form 4, filing 0000899243-22-022373 | |
| 2022-06-10 |
Merrimack Pharmaceuticals Inc MACK |
P, Open-market purchase | 3,653 acquired | 4.92 | 17,974.95 | Form 4, filing 0000899243-22-022373 | |
| 2022-06-10 |
Merrimack Pharmaceuticals Inc MACK |
P, Open-market purchase | 2,733 acquired | 4.92 | 13,448.00 | Form 4, filing 0000899243-22-022373 | |
| 2022-01-31 |
Merrimack Pharmaceuticals Inc MACK |
P, Open-market purchase | 714 acquired | 5.05 | 3,605.20 | Form 4, filing 0000899243-22-003837 | |
| 2022-01-31 |
Merrimack Pharmaceuticals Inc MACK |
P, Open-market purchase | 523 acquired | 5.05 | 2,640.78 | Form 4, filing 0000899243-22-003837 | |
| 2022-01-28 |
Merrimack Pharmaceuticals Inc MACK |
P, Open-market purchase | 11,458 acquired | 4.48 | 51,295.17 | Form 4, filing 0000899243-22-003837 | |
| 2022-01-28 |
Merrimack Pharmaceuticals Inc MACK |
P, Open-market purchase | 1,505 acquired | 4.48 | 6,737.58 | Form 4, filing 0000899243-22-003837 | |
| 2022-01-27 |
Merrimack Pharmaceuticals Inc MACK |
P, Open-market purchase | 16,272 acquired | 4.82 | 78,474.97 | Form 4, filing 0000899243-22-003553 | |
| 2022-01-26 |
Merrimack Pharmaceuticals Inc MACK |
P, Open-market purchase | 19,528 acquired | 5.01 | 97,784.51 | Form 4, filing 0000899243-22-003553 | |
| 2022-01-11 |
Merrimack Pharmaceuticals Inc MACK |
P, Open-market purchase | 76,542 acquired | 4.00 | 306,022.57 | Form 4, filing 0000899243-22-001744 | |
| 2022-01-11 |
Merrimack Pharmaceuticals Inc MACK |
P, Open-market purchase | 14,728 acquired | 4.00 | 58,884.02 | Form 4, filing 0000899243-22-001744 | |
| 2022-01-10 |
Merrimack Pharmaceuticals Inc MACK |
P, Open-market purchase | 8,719 acquired | 3.83 | 33,432.13 | Form 4, filing 0000899243-22-001744 | |
| 2022-01-10 |
Merrimack Pharmaceuticals Inc MACK |
P, Open-market purchase | 5,960 acquired | 3.83 | 22,853.02 | Form 4, filing 0000899243-22-001744 | |
| 2022-01-07 |
Merrimack Pharmaceuticals Inc MACK |
P, Open-market purchase | 5,215 acquired | 3.82 | 19,911.91 | Form 4, filing 0000899243-22-001470 | |
| 2022-01-07 |
Merrimack Pharmaceuticals Inc MACK |
P, Open-market purchase | 3,565 acquired | 3.82 | 13,611.88 | Form 4, filing 0000899243-22-001470 | |
| 2021-01-08 |
Garrett Motion Inc. GTX |
P, Open-market purchase | 62,846 acquired | 4.66 | 293,050.90 | Form 4, filing 0000899243-21-001417 | |
| 2021-01-07 |
Garrett Motion Inc. GTX |
P, Open-market purchase | 16,939 acquired | 4.73 | 80,189.23 | Form 4, filing 0000899243-21-001417 | |
| 2021-01-06 |
Garrett Motion Inc. GTX |
P, Open-market purchase | 67,310 acquired | 4.63 | 311,577.99 | Form 4, filing 0000899243-21-001417 | |
| 2021-01-04 |
Garrett Motion Inc. GTX |
S, Open-market sale | 60,112 disposed | 4.40 | 264,432.69 | Form 4, filing 0000899243-21-001417 | |
| 2021-01-04 |
Garrett Motion Inc. GTX |
P, Open-market purchase | 60,112 acquired | 4.40 | 264,613.02 | Form 4, filing 0000899243-21-001417 | |
| 2020-12-01 |
Merrimack Pharmaceuticals Inc MACK |
P, Open-market purchase | 17,359 acquired | 4.00 | 69,420.38 | Form 4, filing 0000899243-20-032668 | |
| 2020-12-01 |
Merrimack Pharmaceuticals Inc MACK |
P, Open-market purchase | 12,417 acquired | 4.00 | 49,656.82 | Form 4, filing 0000899243-20-032668 | |
| 2020-11-24 |
Merrimack Pharmaceuticals Inc MACK |
P, Open-market purchase | 40,278 acquired | 3.65 | 147,014.70 | Form 4, filing 0000899243-20-032258 | |
| 2020-11-24 |
Merrimack Pharmaceuticals Inc MACK |
P, Open-market purchase | 28,809 acquired | 3.65 | 105,152.85 | Form 4, filing 0000899243-20-032258 | |
| 2020-11-12 |
Merrimack Pharmaceuticals Inc MACK |
P, Open-market purchase | 32,934 acquired | 3.65 | 120,047.72 | Form 4, filing 0000899243-20-031115 | |
| 2020-11-12 |
Merrimack Pharmaceuticals Inc MACK |
P, Open-market purchase | 23,556 acquired | 3.65 | 85,863.98 | Form 4, filing 0000899243-20-031115 | |
| 2020-08-13 |
Merrimack Pharmaceuticals Inc MACK |
P, Open-market purchase | 354 acquired | 3.50 | 1,239.00 | Form 4, filing 0000899243-20-022561 | |
| 2020-08-13 |
Merrimack Pharmaceuticals Inc MACK |
P, Open-market purchase | 254 acquired | 3.50 | 889.00 | Form 4, filing 0000899243-20-022561 | |
| 2020-08-12 |
Merrimack Pharmaceuticals Inc MACK |
P, Open-market purchase | 1,166 acquired | 3.49 | 4,072.84 | Form 4, filing 0000899243-20-022283 | |
| 2020-08-12 |
Merrimack Pharmaceuticals Inc MACK |
P, Open-market purchase | 834 acquired | 3.49 | 2,913.16 | Form 4, filing 0000899243-20-022283 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- P, Open-market purchase
- Open-market purchase
- S, Open-market sale
- Open-market sale
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.
How to cite this page
ebomi catalog. Levy Noah G., insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001788608
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6